Comment on low-dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment-free remission in chronic myeloid leukemia patients: Results of a retrospective study.
| Autor: | Campiotti L; Department of Medicine and Surgery, University of Insubria, Varese, Italy., Suter MB; Medical Oncology, Azienda Socio Sanitaria Territoriale Sette Laghi, Varese, Italy., Dentali F; Department of Medicine and Surgery, University of Insubria, Varese, Italy. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cancer [Cancer] 2021 Mar 15; Vol. 127 (6), pp. 976. Date of Electronic Publication: 2020 Oct 23. |
| DOI: | 10.1002/cncr.33282 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Plný text